UnknownNot Applicable

Non-invasive Brain Stimulation in Patients With Methamphetamine Use Disorder

60 participantsStarted 2022-09-01

Plain-language summary

The study aims to apply the intermittent theta burst transcranial magnetic stimulation (iTBS) treatment and evaluate the effect in improving craving, affective symptoms, and cognitive function for those participants in the community with amphetamine use. An electroencephalography and blood biomarkers will also be examined to explore the possible mechanisms.

Who can participate

Age range20 Years – 65 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Age ranged 20-65.
✓. Diagnosis as amphetamine use disorder by clinical psychiatrist according to DSM-V

Exclusion criteria

✕. Major disorders other than substance use disorders in Diagnostic and Statistics Manual-5 (e.g. Schizophrenia, organic brain syndrome, and bipolar disorders).
✕. Epilepsy, head trauma, migraine, cardiovascular comorbidity, atypical parkinsonian disorder
✕. patients with heart pacemakers, implanted drug delivery aids, artificial electronic ears, implantable defibrillators, and/or implanted nerve stimulators, and near the implants mentioned above.
✕. patients with metal implants above the chest.
✕. people who have damaged skin in areas of the patient's body that receive stimulation.
✕. patients with multiple sclerosis.
✕. patients who have extensive ischemic scarring.
✕. pregnant women.

What they're measuring

Visual analogue scale (Taiwanese version)

Timeframe: Baseline(Week 0, before intervention), Week 4(after iTBS program), Week 8, Week 16

Trial details

NCT IDNCT05535101

SponsorNational Taiwan University Hospital Hsin-Chu Branch

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2022-12-31

Contact for this trial

Cheng-Che Chen, MD, MSc

0972654912 hugocc@gmail.com

View on ClinicalTrials.gov More Craving trials